Advantage of Longer Treatment After Liver Transplant
Share
Follow Us
The Editors at Hepatitis Central
November 11, 2009
Find out about a Henry Ford retrospective study of liver transplant recipients, which discovered that extending antiviral treatment length significantly reduced the chances of Hepatitis C recurring.
Extending Treatment After Liver Transplant May Benefit Patients With Hepatitis C Recurrence
ScienceDaily (Oct. 31, 2009) — Extending hepatitis C treatment for liver transplant patients beyond current practice results in high rates of clearance of the hepatitis C virus from the blood, as well as a low rate of relapse, according to a Henry Ford Hospital study.
“We found that patients who achieved a sustained virological response were more likely to have had extended treatment,” says Kimberly Brown, M.D., Division head of Gastroenterology at Henry Ford Hospital and senior author of the study.
Continue reading the entire article:
http://www.sciencedaily.com/releases/2009/10/091031152432.htm
